Blood Types in Children With COVID-19 | NCT04682912

Studies
Blood Types in Children With COVID-19

NCT04682912

Sponsor

Mersin Training and Research Hospital

Status

Unknown status

Last Update Posted

Feb 3, 2021Actual

Enrollment

2,000Estimated

Phase

Not provided

Conditions

COVID-19 Infection

Interventions

Not provided

Countries

Turkey (Türkiye)

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Jan 2021

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Jan 30, 2021Actual

Primary Completion Date

Feb 2021Estimated

Completion Date

Feb 2021Estimated

First Submitted Date

Dec 22, 2020

First Submission Date that Met QC Criteria

Dec 23, 2020

First Posted Date

Dec 24, 2020Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jan 30, 2021

Last Update Posted Date

Feb 3, 2021Actual

Sponsor/Collaborators Module

Responsible Party, by Official Title

Ali Özdemir, Assoc Prof Ali Özdemir, Mersin Training and Research HospitalPrincipal Investigator

Lead Sponsor

Mersin Training and Research HospitalOTHER_GOV

Collaborators

Name	Class
Mersin University	OTHER
Dicle University	OTHER
Bezmialem Vakif University	OTHER
Uludag University

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

It is speculated that in adult patients with COVID-19 blood type A is associated with the worst outcome, while blood type O is associated with mild symptoms.To our knowledge, there has been no such a study investigated ABO and Rhesus (Rh) blood group types in children with COVID-19 infection yet. Therefore, the study aimed to examine if such a correlation exists in children infected with COVID-19.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

2,000Estimated

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Patient medical files	ABO blood type distribution will be different in COVID-19	1 month

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

The study period consisted between March 2020 and December 2020
Children with a documented positive COVID-19 nasal smear real-time reverse-transcriptase polymerase chain reaction (PCR) assay were included.

Exclusion Criteria:

Patients who had a past medical history of any chronic illness (related to respiratory, cardiology, immunology, neurology, metabolic, etc) were excluded.

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

1 Month

Maximum Age

18 Years

Standard Ages

ChildAdult

Study Population

A retrospective multicenter trial in five major hospitals in Turkey to determine whether ABO and Rh blood types carry any risk/beneficial factor among children with COVID-19 infection.

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Ali̇ Özdemi̇r, MD	Contact	03242251000		aliozdemir@hotmail.com

Overall Officials

Name	Affiliation	Role
Ali̇ Özdemi̇r, MD	Mersi̇n Şehi̇r Eği̇ti̇m Ve Araşti̇rma Hastanesi̇	Principal Investigator
Ali̇ Özdemi̇r	Mersi̇n Şehi̇r Eği̇ti̇m Ve Araşti̇rma Hastanesi̇	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Mersin City Training & Research Hospital	Recruiting	Mersi̇n		33240	Turkey (Türkiye)

Condition Browse Module

MeSH Terms

ID	Term
D000086382	COVID-19

Ancestor Terms

ID	Term
D011024	Pneumonia, Viral
D011014	Pneumonia
D012141	Respiratory Tract Infections
D007239	Infections

Browse Leaves

Not provided

Browse Branches

Not provided